Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.
Also called NCT03551548
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,500 participants
- Registry
-
NCT03551548
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT03551548. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2021-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
- Acronym
- ALDOCURE
- Condition
- Cardiac Surgery
- Condition
- Atrial Fibrillation
- Condition
- Aldosterone Blockade
- Intervention (Drug)
- Spironolactone 25mg
- Intervention (Drug)
- Placebo oral capsule
- Lead sponsor
- University Hospital, Caen
- Collaborator
- Ministry of Health, France
Record details
- Record id
cardio:ct-nct03551548- Content hash
7a2ba71d6eab20d19f2deef16c9f9997615985396435666c59829f468d6c69a6